Literature DB >> 11142579

Therapeutic effects of an oral adsorbent on acute dextran sulphate sodium-induced colitis and its recovery phase in rats, especially effects of elimination of bile acids in gut lumen.

Y Araki1, T Tsujikawa, A Andoh, M Sasaki, Y Fujiyama, T Bamba.   

Abstract

BACKGROUND: The pathogenesis of inflammatory bowel disease is still unknown. However, it is possible that faecal bile acids influence the clinical course. AIMS: To evaluate the eliminating effects of faecal bile acids by the oral adsorbent on dextran sulphate sodium-induced rat colitis.
METHODS: Rats were given 3% dextran sulphate sodium aqueous solution for 7 days, with or without concomitant administration of oral adsorbent, or the rats were given dextran sulphate sodium for 7 days, followed with or without oral adsorbent for 5 days. Macroscopic and microscopic examinations of the colons and measurement of faecal bile acids were performed. The cytotoxicity of bile salts on Caco-2 cells was also evaluated.
RESULTS: Oral adsorbent tended to attenuate the dextran sulphate sodium-induced colitis. Oral adsorbent was fairly effective in reducing faecal hyodeoxycholic acid concentration. A positive correlation was found between the size of the ulcer area and the faecal hyodeoxycholic acid concentration. In a cell culture study, cytotoxicity of bile acid was parallel with increasing hydrophobicity of the bile acid. However, hyodeoxycholate exhibited severe cytotoxicity, despite its hydrophilic properties.
CONCLUSIONS: Oral adsorbent tended to attenuate the dextran sulphate sodium-induced colitis and tended to promote the recovery process. It is possible that bile acids in the gut lumen influence the progression of dextran sulphate sodium-induced colitis and its repair process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11142579     DOI: 10.1016/s1590-8658(00)80332-1

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  6 in total

Review 1.  The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspective.

Authors:  Paula Mosińska; Martin Storr; Jakub Fichna
Journal:  Therap Adv Gastroenterol       Date:  2015-09       Impact factor: 4.409

2.  The herbal medicine rikkunshito exhibits strong and differential adsorption properties for bile salts.

Authors:  Yoshio Araki; Ken-Ichi Mukaisho; Yoshihide Fujiyama; Takanori Hattori; Hiroyuki Sugihara
Journal:  Exp Ther Med       Date:  2012-02-09       Impact factor: 2.447

3.  AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled study.

Authors:  Walter Reinisch; Simon Travis; Stephen Hanauer; Hong Wang; Nawar Shara; M Scott Harris
Journal:  Inflamm Bowel Dis       Date:  2014-05       Impact factor: 5.325

4.  Isomaltulose Exhibits Prebiotic Activity, and Modulates Gut Microbiota, the Production of Short Chain Fatty Acids, and Secondary Bile Acids in Rats.

Authors:  Zhan-Dong Yang; Yi-Shan Guo; Jun-Sheng Huang; Ya-Fei Gao; Fei Peng; Ri-Yi Xu; Hui-Hui Su; Ping-Jun Zhang
Journal:  Molecules       Date:  2021-04-23       Impact factor: 4.411

5.  Cattle bile aggravates diclofenac sodium-induced small intestinal injury in mice.

Authors:  Hironori Ishikawa; Shiro Watanabe
Journal:  Evid Based Complement Alternat Med       Date:  2011-04-11       Impact factor: 2.629

6.  Molecular Properties of Guar Gum and Pectin Modify Cecal Bile Acids, Microbiota, and Plasma Lipopolysaccharide-Binding Protein in Rats.

Authors:  Tannaz Ghaffarzadegan; Nittaya Marungruang; Frida Fåk; Margareta Nyman
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.